Toggle Contrast

Pan London Cancer Alliances Research Fellowships

Since 2016, cancer alliances across London have come together through the Pan London Cancer Alliances Research Consortium to fund a number of cancer research fellowships to improve cancer care and experience.

Research fellowships are offered to pre-doctoral individuals interested in healthcare improvement, including clinicians, nurses and allied health professionals (AHP) who wish to obtain further research experience.

Over the past years, the areas of focus have been aligned to meet the ambitions of the NHS Long Term Plan:

  • Earlier diagnosis: with a focus on access into primary care and/or diagnostics, or increasing uptake into cancer screening programmes from a population or place-based approach. Also includes aspects of improving detection of recurrent cancer and/or surveillance strategies of the high risk population.
  • Cancer inequalities: exploring variations in all aspects of cancer care throughout the patient journey, including screening, treatment and supportive care. A recent focus is the use of digital health and its role in identifying and addressing inequalities and inequities along the cancer pathway.
  • Personalised care of people living with and beyond cancer: optimisation of patient management during and after cancer treatment to improve quality of life and clinical outcomes, including multi-morbidity reviews and generation of evidence base for the cancer care reviews.

Successful applicants are awarded by the Fellowship Selection Committee, comprised of clinical and academic experts from across London and representation from the cancer alliances and the NIHR Biomedical Research Centres (BRCs) at Imperial College Healthcare Trust/Imperial College, and The Royal Marsden/Institute of Cancer Research London.

For more information please contact

  • Dr Oluwatomilayo Ehinon Ejedenawe. ‘Treatment refusal decisions among women from Black ethnic background with gynaecological cancer.’
  • Dr Rose Hall. ‘Targeted early prostate cancer detection in higher risk groups (PROFILE studies).’
  • Joanne Land. ‘Feasibility of an exercise intervention for myeloma patients who are being treated with a brace for spinal fractures.’
  • Ellie Ware. ‘Active and early nutritional intervention to improve outcomes for patients with ovarian cancer.’

  • Dr Harris Gousis. ‘Improving diagnostics and therapeutics in never-smoker lung cancer patients.’
  • Laura Monje-Garcia. ‘Opening Pandora’s box: the Psychological Impacts of living with an inherited colorectal cancer predisposition syndrome (PSYLIVED).’
  • Dr Sarah Noakes. ‘Psycho-social function and support preferences for people with cancer who cannot vaccinate in the context of Covid recovery.’
  • Ms Hannah Warren. ‘Sestamibi Kidney for the Assessment for renal Neoplasms (SKAN).’
  • Dr Maham Zaman. ‘Hairdressing salons to promote NHS online application to reduce underdiagnosis of breast cancers among women in London’s deprived and ethnically diverse neighbourhoods: a feasibility study.’
  • Rhia Kaur. ‘Underpinning the development of a prehabilitation intervention for women with gynaecological cancer: scoping review and qualitative study.’
  • Soh-yon Park. ‘Participatory research and design to equity for cancer care.’
  • Parris Williams. ‘Delivering smoking cessation in the context of lung health checks.’


  • Dr Paula Adkin. ‘The prevalence and impact of gastrointestinal, urinary and sexual dysfunction following abdomino-pelvic radiotherapy for childhood, teenage and young adult cancers.’
  • Man-Chie Chow. ‘Understanding the incidence of anxiety and depression following cancer treatment using The Health Improvement Network (THIN) data.’
  • Dr Benjamin Hunter. ‘Radiomics and AI stratification of incidental lung nodules.’
  • Jennifer McCracken. ‘What factors should be considered when making a shared decision with patient and carers to commence and discontinue artificial nutrition at end of life?’
  • James Tallant. ‘Developing personalised, low-burden quality of life assessments for patients living with brain tumours.’
  • Mr Theo Georgiou Delisle. ‘The acceptability of FIT test and patient experience when used as triaging tool in patients with suspected colorectal symptoms.’
  • Dr Catherine Lecat. ‘Implementing the Promoting Individualised Self-Management for Myeloma Survivorship (PrISMS) clinic.’
  • Dr Javieria Martelli. ‘Predictors of hospitalisation in the last months of life for people with cancer: retrospective cohort study using linked data.’
  • Katherine Pike. ‘Developing a brain tumour imaging dataset.’
  • Ms Annabel Shaw. ‘The PRESERVE Project – PRE-therapeutic MRI assessment of Early StagE Rectal Cancer and significant Rectal Polyps to aVoid major resectional surgery: a new approach to the management of early stage rectal cancer.’
  • Suzanne Tugnait. ‘Childhood cancer outcomes research linking national registry data to clinical trial databases – a pilot project using childhood renal tumours as the exemplar.’
  • Victoria Aubrey. ‘Development of a feasibility study for diet and exercise intervention for those living with and beyond cancer (colo-rectal and breast).’
  • Ms Rebecca Bott. ‘Risk stratification in oesophago-gastric cancer surgery: A focus on co-morbidity and elderly patients having high risk surgery.’
  • Dr Joanne Evans. ‘cfDNA as a prognostic marker in hepatocellular carcinoma.’
  • Gemma Pugh. ‘Feasibility pilot of a health behaviour change intervention for TYA cancer survivors.’
  • Dr Elwira Szychot. ‘Establishing a framework for monitoring clinical and radiological parameters in children, teenagers and young adults treated with brain irradiation.’
  • Dr Anna Weil. ‘The second conversation – a mixed methods study investigating a novel educational intervention to improve junior doctors’ skills and confidence in conducting end of life care conversations.’
  • Dr Lucy Dumas. ‘Improving outcomes for older women with ovarian cancer.’
  • Denise Flett. ‘Development of a manualised brief cognitive behavourial (CBT) psycho-educational/psychosexual training programme for clinical nurse specialists working with women experiencing treatment-induced sexual difficulties after breast cancer.’
  • Tim Hoogenboom. ‘Multi parametric US for the assessment and clinical management of NAFLD and HCC: a proof of concept study.’
  • Dr Thomas Round. Urgent referral of persons with suspected cancer: understanding the variation in London.’